R.A. Shourbaji

Mount Sinai Beth Israel

Papers

1

Total Citations

9

H-Index

1

About

R.A. Shourbaji is a leading surgical oncologist whose research focuses on refining treatment strategies for squamous cell carcinoma of the head and neck, with a particular emphasis on the role of transoral robotic surgery (TORS). His most cited work, a 2013 study with 9 citations, critically examines a key clinical dilemma: while TORS has revolutionized the surgical management of head and neck cancers by offering a minimally invasive approach, it does not address the neck or retropharyngeal nodes (RPN). Shourbaji’s major contribution lies in highlighting the increased risk of RPN recurrence when TORS is performed without adjuvant radiotherapy. This finding has significant implications for treatment planning, urging clinicians to carefully consider postoperative radiation to mitigate locoregional failure. By identifying this gap in oncologic safety, Shourbaji’s work helps bridge the surgical and radiotherapeutic management of head and neck cancers, ultimately guiding more comprehensive, multidisciplinary care. His research continues to impact the evolving landscape of robotic surgery and adjuvant therapy, making him a notable voice in head and neck oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Lack of Adjuvant Radiotherapy May Increase Risk of Retropharyngeal Node Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck after Transoral Robotic Surgery
9 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Mount Sinai Beth Israel

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago